514 related articles for article (PubMed ID: 36555823)
1. Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence.
Zavala-Tecuapetla C; Luna-Munguia H; López-Meraz ML; Cuellar-Herrera M
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555823
[TBL] [Abstract][Full Text] [Related]
2. Cannabis for the Treatment of Epilepsy: an Update.
Gaston TE; Szaflarski JP
Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid treatments in epilepsy and seizure disorders.
Devinsky O; Jones NA; Cunningham MO; Jayasekera BAP; Devore S; Whalley BJ
Physiol Rev; 2024 Apr; 104(2):591-649. PubMed ID: 37882730
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.
Del Pozo A; Barker-Haliski M
Exp Neurol; 2023 Feb; 360():114288. PubMed ID: 36471511
[TBL] [Abstract][Full Text] [Related]
5. Use of cannabidiol in the treatment of epilepsy.
Mazurkiewicz-Bełdzińska M; Zawadzka M
Neurol Neurochir Pol; 2022; 56(1):14-20. PubMed ID: 35211946
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of cannabinoids in the treatment of epilepsy.
Gaston TE; Friedman D
Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
9. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry.
Bellocchio L; Patano A; Inchingolo AD; Inchingolo F; Dipalma G; Isacco CG; de Ruvo E; Rapone B; Mancini A; Lorusso F; Scarano A; Malcangi G; Inchingolo AM
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298644
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids in epilepsy: clinical efficacy and pharmacological considerations.
Espinosa-Jovel C
Neurologia (Engl Ed); 2023; 38(1):47-53. PubMed ID: 34824031
[TBL] [Abstract][Full Text] [Related]
12. From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?
Lippiello P; Balestrini S; Leo A; Coppola A; Citraro R; Elia M; Russo E; De Sarro G
Curr Pharm Des; 2016; 22(42):6426-6433. PubMed ID: 27587196
[TBL] [Abstract][Full Text] [Related]
13. Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials.
Silvestro S; Mammana S; Cavalli E; Bramanti P; Mazzon E
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013866
[TBL] [Abstract][Full Text] [Related]
14. The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
Reddy DS
Clin Pharmacol Ther; 2017 Feb; 101(2):182-184. PubMed ID: 27506704
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).
Klein BD; Jacobson CA; Metcalf CS; Smith MD; Wilcox KS; Hampson AJ; Kehne JH
Neurochem Res; 2017 Jul; 42(7):1939-1948. PubMed ID: 28478594
[TBL] [Abstract][Full Text] [Related]
16. Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy.
Anderson LL; Heblinski M; Absalom NL; Hawkins NA; Bowen MT; Benson MJ; Zhang F; Bahceci D; Doohan PT; Chebib M; McGregor IS; Kearney JA; Arnold JC
Br J Pharmacol; 2021 Dec; 178(24):4826-4841. PubMed ID: 34384142
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy.
Yao I; Stein ES; Maggio N
Pharmacol Ther; 2019 Oct; 202():32-39. PubMed ID: 31176695
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol in canine epilepsy.
Potschka H; Bhatti SFM; Tipold A; McGrath S
Vet J; 2022 Dec; 290():105913. PubMed ID: 36209995
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications.
Tambe SM; Mali S; Amin PD; Oliveira M
J Integr Med; 2023 May; 21(3):236-244. PubMed ID: 36973157
[TBL] [Abstract][Full Text] [Related]
20. Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures.
Mascal M; Hafezi N; Wang D; Hu Y; Serra G; Dallas ML; Spencer JPE
Sci Rep; 2019 May; 9(1):7778. PubMed ID: 31123271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
